Michael Cooreman

Company: Inventiva Pharma

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Comparing & Contrasting Single, Dual & Triple NASH Therapy Treatment Options for NASH 2:30 pm

• Outlining the relative benefits & drawbacks of combination therapies in comparison to monotherapies – are these the future of NASH treatment? • Examining the latest research on combination therapies to understand how to identify which factors you must consider when deciding to combine separate drugs when treating NASH patients. • Designing a combination therapy…Read more

day: Day Two